Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2019, Vol. 15 ›› Issue (04): 472 -475. doi: 10.3877/cma.j.issn.1673-5250.2019.04.020

Special Issue:

Review

Hyperprolactinemia and menstrual disorder caused by antipsychotics

Xiaolin You1, Cong Xie1   

  1. 1. Department of Obstetrics and Gynecology, The Affiliated Hospital, School of Medicine, USETC Chengdu Women′s & Children′s Central Hospital, Chengdu 610041, Sichuan Province, China
  • Received:2019-01-10 Revised:2019-07-16 Published:2019-08-01
  • About author:
    Corresponding author: Gan Xiaoqin, Email:
  • Supported by:
    Program of Health and Family Planning Commission of Sichuan Province(17PJ412)

Antipsychotics (APS) can be divided into typical and atypical APS. Hyperprolactinemia (HPRL) is characterized by an abnormal increase in prolactin level of peripheral blood circulation. All typical APS and atypical APS risperidone can lead to the serum prolactin level of women with mental illness significantly higher than normal value. While most atypical APS only result in transient and slightly increase of serum prolactin level or even do not lead to the increase of serum prolactin level. HPRL caused by APS is one of the main reasons for menstrual disorders and amenorrhea in women with mental illness. The treatments of HPRL, menstrual disorders and amenorrhea caused by APS are mainly to reduce level of prolactin. The incidences of HPRL and menstrual disorders caused by different APS are different. Accurate clinical evaluation and management of HPRL can improve the quality of life and compliance of female psychiatric patients. This review expounds the treatment of adverse reactions HPRL and menstrual disorders caused by APS in treatment of female psychiatric patients, in order to provide reference for clinical reduction of adverse reactions in female psychiatric patients.

[1]
中华医学会妇产科学分会内分泌学组. 女性高催乳素血症诊治共识[J]. 中华妇产科杂志,2016, 51(3): 161-168.
[2]
Ajmal A,Joffe H, Nachtigall LB. Psychotropic-induced hyperprolactinemia: a clinical review[J]. Psychosomatics, 2014, 55(1): 29-36.
[3]
Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications[J]. World Psychiatry, 2018, 17(3): 341-356.
[4]
González-Blanco L, Greenhalgh AMD, Garcia-Rizo C, et al. Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: a Meta-analysis[J]. Schizophr Res, 2016, 174(1-3): 156-160.
[5]
Stubbs B, De Hert M, Sepehry AA, et al. A Meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia[J]. Acta Psychiatr Scand, 2014, 130(6): 470-486.
[6]
Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a Meta-analysis of cancer incidence in 577 013 participants of 50 observational studies[J]. Psychother Psychosom, 2014, 83(2): 89-105.
[7]
周平,刘联琦,郝军锋,等. 阿立哌唑预防女性分裂症患者抗精神病药所致高泌乳素血症的研究[J]. 国际精神病学杂志,2014, 41(2): 68-72.
[8]
邓良华,刘青梅,郑庆梅. 非典型抗精神病药引起女性闭经的调查[J]. 吉林医学,2008, 29(15): 1254-1255.
[9]
Melkersson K. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients[J]. J Clin Psychiatry, 2005, 66(6): 761-767.
[10]
Bargiota SI, Bonotis KS, Messinis IE, et al. The effects of antipsychotics on prolactin levels and women′s menstruation[J]. Schizophr Res Treatment, 2013, 2013: 502697.
[11]
赵中健,孔德荣,李猛,等. 阿立哌唑、齐拉西酮与利培酮对女性精神分裂症患者雌二醇水平的影响[J]. 精神医学杂志,2015, 28(1): 13-15.
[12]
Chen JX, Su YN, Bian QT, et al. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: a randomized, double-blind, placebo-controlled, dose-response study[J]. Psychoneuroendocrinology, 2015, 58: 130-140.
[13]
Yoon HW, Lee JS, Park SJ, et al. Comparing the effectiveness and safety of the addition of and switching toaripiprazole for resolving antipsychotic-induced hyperprolactinemia: a multicenter, open-label, prospective study[J]. Clin Neuropharmacol, 2016, 39(6): 288-294.
[14]
Bargiota SI, Bonotis K, Messinis IE, et al. Hyperprolactinaemia: psychological aspects and menstrual attitudes of women with schizophrenia[J]. Psychiatry Res, 2015, 226(2-3): 525.
[15]
喻东山,高振忠. 精神科合理用药手册[M]. 南京:江苏科学技术出版社,2005: 65-170.
[16]
Marken PA,Haykal RF, Fisher JN. Management of psychotropic-induced hyperprolactinemia[J]. Clin Pharm, 1992, 11(10): 851-856.
[17]
余云香,吕那,李宇晨,等. 抗精神病药物致高泌乳素血症对女性精神病患者卵巢功能的影响[J]. 中国医药指南,2016, 14(26): 7-8.
[18]
Canuso CM, Goldstein JM,Wojcik J, et al. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder[J]. Psychiatry Res, 2002, 111(1): 11-20.
[19]
Chen HZ,Qian MC, Shen XH, et al. Risk factors for medication-induced amenorrhea in first-episode female Chinese patients with schizophrenia treated with risperidone[J]. Shanghai Arch Psychiatry, 2013, 25(1): 40-47.
[20]
Reynolds-May MF,Kenna HA, Marsh W, et al. Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls[J]. Bipolar Disord, 2014, 16(1): 37-47.
[21]
郑婵燕,周平,李祎鋆,等. 逍遥丸治疗女性精神分裂症患者抗精神病药致高泌乳素血症的对照研究[J]. 实用医学杂志,2015, 31(2): 309-311.
[22]
苏珊娜,刘临兰,杨宇,等. 丹溪治湿痰方治疗抗精神病药物所致闭经临床观察[J]. 深圳中西医结合杂志,2016, 26(16): 48-49.
[1] Jiechun Shi, Ziyu Fan, Yan Xing. Early warning efficiency of different screening methods on cervical adenocarcinoma in situ[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 575-581.
[2] Shuqin Zhang, Lian Chen. Diagnosis and treatment of postpartum intrauterine retained products of conception[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 493-497.
[3] Dan Tang, Xiaoxi Yao, Bowen Yang, Shaolong Xue, Mengyao Li, Liuxing Wei, Mingrong Xi. The impact of doublecortin-like kinase 1 on the clinical characteristics of endometrioid adenocarcinoma patients[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 582-590.
[4] Yi Wei, Yuxi Zhou, Ye Yang, Xiufeng Ling, Chun Zhao. Current research status on roles of microRNA on endometrial receptivity[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 266-270.
[5] Lin Lin, Simeng Tian, Yonghua Yu, Feifei Xu, Mingli Huang. Current research status on treatment of intrauterine adhesion by stem cells and their exosomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 271-275.
[6] Xin Li, Yi Wei, Juan Zhang, Juanjuan Zhang, Xiufeng Ling, Chun Zhao, Mianqiu Zhang. Influencing factors on clinical pregnancy outcomes of frozen-thaw embryo transfer cycle in women of advanced age[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 276-283.
[7] Weicong Gao, Li Li, Zhonghua Zhang, Xianghui Zhu, Suqiao Liu. Impact of impaired glucose regulation on recurrence within 2 years after modified radical surgery in patients with cervical cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 231-237.
[8] Yuping Li, Hui Ma, Hang Yu. Clinical efficacy of laparoscopic uterine artery ligation combined with myomectomy for the treatment of uterine fibroids[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 238-244.
[9] Lin Yang, Rutie Yin. Current research status on etiology and treatment of patients with white lesions of vulva[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 157-165.
[10] Li Wang, Yueying Wang, Fen Zhou, Yukun Guo, Lina Wei. Current research status in effect of gonadotropin-releasing hormone antagonist on endometrial receptivity[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 629-635.
[11] Ran Jiang, Caiyan Zou, Yiquan Sang. Serum sex hormone levels in patients with cervical intraepithelial neoplasia grade Ⅲ and its relationship with high-risk human papillomavirus infection[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 683-688.
[12] Likun Wei, Xuhong Zhang, Ying Luo, Fengxia Xue, Yingmei Wang, Xueru Song, Lina Tian, Yanfang Zhang, Yanxia Wang, Wenyan Tian. Malignant transformation of ovarian endometrioma and pelvic abscesses: a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 696-702.
[13] Yuan Wu, Biqing Zhu, Dan He, Hairong Wang, Qian Li. Construction of a prognostic nomogram model and risk stratification system for cervical cancer patients with intensity modulated radiation therapy and after-loading therapy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 734-744.
[14] Juan Gu, Qingqing Sun, Fangfang Hu, Yijuan Cao, Yujuan Qi. Clinical application of endometrial receptivity array to improve pregnancy outcomes in women with repeated embryo implantation failure[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 582-587.
[15] Yang Zhou, Shulan Lyu. Diagnosis and treatment of hyperprolactinemia during periconception[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(01): 24-28.
Viewed
Full text


Abstract